Pictet Asset Management
MBX

Pictet Asset Management’s MBX Biosciences MBX Stock Holding History

Pictet Asset Management’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
+4,098
New +$143K ﹤0.01% 1924

Other funds holding MBX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Pictet Asset Management's MBX Position: Q2 2026 in Review

Pictet Asset Management opened a new position in MBX Biosciences (MBX) in Q2 2026: 4,098 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #1924 among its holdings.

50 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Pictet Asset Management held 4,098 shares of MBX Biosciences worth $226K as of Q2 2026.
  • MBX Biosciences was a new Pictet Asset Management position in Q2 2026.
  • MBX Biosciences made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1924 holding.
  • 50 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.